Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.